P1-175Heterogeneity of EGFR-mutant and PD-L1 High-Expressing Clones Affects Treatment Efficacy of EGFR-TKI and PD-1 Inhibitor
Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdy375.016
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV